Drugs.com New Drug ApprovalsOriginal article
Viatris Receives U.S. FDA Approval for Ryzumvi for the Treatment of Presbyopia
RegulatoryapprovedRyzumviPositive
AI Analysis
Summary
Viatris announced that the FDA has approved Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia. The announcement was made on October 16, 2026.
Outcome Details
FDA approved Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia.
Importance:7/10
Sentiment:
0.60
FDA approvalophthalmologypresbyopiaophthalmic solutionViatris
Related Companies
Read the original article
Published by Drugs.com New Drug Approvals on October 16, 2026 1:10 AM